08699350 · Active · incorporated 12 years, 11 months ago · Manchester
Biotech Biotech & Life Sciences Drug Discovery Series B+
Develops novel therapeutics to improve healthspan, focusing on inflammatory diseases.
Akl Therapeutics is a private limited company registered at Companies House under number 08699350, incorporated on 20 September 2013, with a registered office in Manchester. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 67 filings for this company, including 7 funding rounds. Its most recent round closed in December 2025, raising £2.1m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 7 | Dec 2025 | £2.1m | £75.00 |
| Round 6 | Dec 2023 | £6.4m | £144.00 |
| Round 5 | Aug 2020 | £2.5m | £120.00 |
| Round 4 | Dec 2019 | £1.4m | £53.00 |
| Round 3 | Jul 2017 | £366k | £53.00 |
| Round 2 | Sep 2016 | £209k | £31.00 |
Showing the 6 most recent of 7 rounds.
Showing the 11 most recent of 67 filings.
See the complete cap table with every shareholder, founder tags, dilution across 17 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.